We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.18%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$325B
AUM Growth
-$10.8B
(-3.2%)
Cap. Flow
-$13.4B
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
22.35%
Holding
3,492
New
145
Increased
887
Reduced
2,282
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$899M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$895M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$597M |
| 4 |
Clarivate
CLVT
|
+$315M |
| 5 |
Mastercard
MA
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.03B |
| 2 |
Apple
AAPL
|
+$962M |
| 3 |
Intel
INTC
|
+$470M |
| 4 |
Microsoft
MSFT
|
+$449M |
| 5 |
Home Depot
HD
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.56% |
| 2 | Financials | 13.11% |
| 3 | Healthcare | 12.33% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KALV
2576
DELISTED
KalVista Pharmaceuticals
KALV
| $2.35M | ﹤0.01% |
122,122
-237
| -0.2% | -$4.8K |
|
2577
Gossamer Bio
GOSS
$87M
| $2.33M | ﹤0.01% |
221,959
-6,388
| -3% | -$58.8K |
|
2578
CRA International
CRAI
$1.06B
| $2.33M | ﹤0.01% |
25,163
-2,845
| -10% | -$257K |
|
2579
Uranium Energy
UEC
$5.57B
| $2.32M | ﹤0.01% |
715,914
+14,256
| +2% | +$35.7K |
|
2580
Praxis Precision Medicines
PRAX
$10.1B
| $2.32M | ﹤0.01% |
8,348
+348
| +4% | +$94.4K |
|
|
LL
2581
DELISTED
LL Flooring Holdings, Inc.
LL
| $2.31M | ﹤0.01% |
118,707
-10,729
| -8% | -$212K |
|
|
CHUY
2582
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $2.31M | ﹤0.01% |
74,336
-47,821
| -39% | -$1.57M |
|
2583
Barrett Business Services
BBSI
$804M
| $2.31M | ﹤0.01% |
125,104
-3,836
| -3% | -$71.8K |
|
2584
TFS Financial
TFSL
$4.93B
| $2.3M | ﹤0.01% |
120,858
+8,597
| +8% | +$168K |
|
2585
Ducommun
DCO
$2.98B
| $2.3M | ﹤0.01% |
44,922
-1,100
| -2% | -$57.7K |
|
2586
Stagwell
STGW
$2.24B
| $2.3M | ﹤0.01% |
299,957
+72,856
| +32% | +$486K |
|
2587
Boston Omaha
BOC
$436M
| $2.29M | ﹤0.01% |
68,198
+1,255
| +2% | +$41.4K |
|
2588
Bristow Group
VTOL
$1.36B
| $2.29M | ﹤0.01% |
72,465
+43,968
| +154% | +$1.28M |
|
|
GOCO
2589
DELISTED
GoHealth
GOCO
| $2.28M | ﹤0.01% |
11,551
-1,726
| -13% | -$183K |
|
2590
York Water
YORW
$514M
| $2.28M | ﹤0.01% |
51,245
+841
| +2% | +$40.3K |
|
2591
HF Foods Group
HFFG
$83.4M
| $2.27M | ﹤0.01% |
375,888
-15,585
| -4% | -$86.8K |
|
|
KDNY
2592
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.27M | ﹤0.01% |
178,155
-6,231
| -3% | -$82K |
|
|
TRHC
2593
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.27M | ﹤0.01% |
73,805
-2,113
| -3% | -$77.8K |
|
|
THR
2594
DELISTED
Thermon Group Holdings
THR
| $2.25M | ﹤0.01% |
139,962
-3,665
| -3% | -$60.9K |
|
|
MOMO
2595
Hello Group
MOMO
$866M
| $2.25M | ﹤0.01% |
212,379
+41,500
| +24% | +$520K |
|
2596
Alaunos Therapeutics
TCRT
$4.86M
| $2.23M | ﹤0.01% |
8,185
+33
| +0.4% | +$10.1K |
|
2597
Phathom Pharmaceuticals
PHAT
$692M
| $2.23M | ﹤0.01% |
69,595
-24,490
| -26% | -$814K |
|
2598
Caesarstone
CSTE
$79.5M
| $2.22M | ﹤0.01% |
169,744
-22,373
| -12% | -$300K |
|
2599
Lifestance Health
LFST
$4.14B
| $2.22M | ﹤0.01% |
+152,849
| New | +$2.94M |
|
2600
First Community Bankshares
FCBC
$911M
| $2.21M | ﹤0.01% |
75,565
-4,436
| -6% | -$134K |
|
Similar funds
VFT
Nuveen's Q3 2021 Portfolio in Review
As of Q3 2021, Nuveen held 3,492 positions worth $325B, down 3.2% from $335B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen withdrew a net $13.4B in Q3 2021, closing 80 positions and reducing 2,282 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $219M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Nuveen opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $596M.
- Nuveen's largest Q3 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 6,810,000 shares worth $596M.
- Nuveen added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2021, an estimated $899M increase.
- Nuveen's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $1.03B.
- Nuveen fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $219M.
- Nuveen's ten largest holdings make up 22% of its $325B portfolio in Q3 2021.
- Nuveen opened 145 new positions and closed 80 in Q3 2021.
- Nuveen's portfolio value fell 3.2% quarter-over-quarter to $325B.
Based on Nuveen's 13F filing for Q3 2021, filed 12 Nov 2021.